These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38447066)

  • 21. Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature.
    Chow R; Herrstedt J; Aapro M; Chiu L; Lam H; Prsic E; Lock M; DeAngelis C; Navari RM
    Support Care Cancer; 2021 Jul; 29(7):3439-3459. PubMed ID: 33442782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Olanzapine 5 mg versus 10 mg for the Prophylaxis of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving High Emetic Risk Chemotherapy without Neurokinin-1 Receptor Antagonist.
    Sukauichai S; Ketkaew C; Othaganont N; Pichaya P; Promsuwan P
    Asian Pac J Cancer Prev; 2022 Jun; 23(6):2137-2143. PubMed ID: 35763658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study.
    Flank J; Schechter T; Gibson P; Johnston DL; Orsey AD; Portwine C; Sung L; Dupuis LL
    Support Care Cancer; 2018 Feb; 26(2):549-555. PubMed ID: 28856448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
    Navari RM; Nagy CK; Gray SE
    Support Care Cancer; 2013 Jun; 21(6):1655-63. PubMed ID: 23314603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
    Wickham R
    Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.
    Vimolchalao V; Sakdejayont S; Wongchanapai P; Sukprakun S; Angspatt P; Thawinwisan W; Chenaksara P; Sriuranpong V; Vinayanuwatikun C; Parinyanitikun N; Poovorawan N; Tanasanvimon S
    Int J Clin Oncol; 2020 Feb; 25(2):396-402. PubMed ID: 31776732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rolapitant approved for chemotherapy-induced nausea and vomiting.
    Traynor K
    Am J Health Syst Pharm; 2015 Nov; 72(21):1838. PubMed ID: 26490812
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-dose olanzapine, sedation and chemotherapy-induced nausea and vomiting: a prospective randomized controlled study.
    Mukhopadhyay S; Dutta P; Banerjee S; Bhattacharya B; Biswas S; M Navari R
    Future Oncol; 2021 Jun; 17(16):2041-2056. PubMed ID: 33792376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An audit of chemotherapy-induced nausea and vomiting in children.
    Clinton F; Dowling M; Capra M
    Nurs Child Young People; 2012 Sep; 24(7):18-23. PubMed ID: 23155937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
    Chow R; Chiu L; Navari R; Passik S; Chiu N; Popovic M; Lam H; Pasetka M; Chow E; DeAngelis C
    Support Care Cancer; 2016 Feb; 24(2):1001-1008. PubMed ID: 26530228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IV aprepitant (Cinvanti) for chemotherapy-induced nausea and vomiting.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):e200-e201. PubMed ID: 30653479
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial.
    Iihara H; Shimokawa M; Gomyo T; Fujita Y; Yoshida T; Funaguchi N; Minato K; Kaito D; Osawa T; Yamada M; Hirose C; Suzuki A; Ohno Y
    BMJ Open; 2019 Jul; 9(7):e028056. PubMed ID: 31278102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine (5 mg) plus standard triple antiemetic therapy for the prevention of multiple-day cisplatin hemotherapy-induced nausea and vomiting: a prospective randomized controlled study.
    Gao J; Zhao J; Jiang C; Chen F; Zhao L; Jiang Y; Li H; Wang W; Wu Y; Jin Y; Da L; Liu G; Zhang Y; Li H; Zhang Z; Jin G; Li Q
    Support Care Cancer; 2022 Jul; 30(7):6225-6232. PubMed ID: 35449368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Dose Olanzapine in the Prevention and Treatment of Carboplatin Induced Nausea and Vomiting: A Prospective Clinical Randomized Controlled Trial.
    An Y; Zhang Z; Gu M; Zhao J; Jiang C; Zhao L; Jiang Y; Li H; Liu G; Jin G; Li Q
    Curr Pharm Des; 2023; 29(23):1867-1874. PubMed ID: 37539930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug.
    Zhang XL; Ying JE
    Curr Oncol; 2022 Oct; 29(11):8235-8243. PubMed ID: 36354710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy-induced nausea and vomiting.
    Scogna DM; Smalley RV
    Am J Nurs; 1979 Sep; 79(9):1562-4. PubMed ID: 258563
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of nausea and vomiting caused by cancer chemotherapy.
    Laszlo J
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():3-9. PubMed ID: 6299552
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial.
    Maeda A; Yoshida H; Inoue H; Ejiri M; Yamaguchi S; Kushihara H; Yamamoto Y; Ando Y; Sato Y; Tashiro Y; Hasegawa A; Takahara Y; Mizutani M; Oze I; Shimizu J
    Ann Palliat Med; 2021 Mar; 10(3):2699-2708. PubMed ID: 33615803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.